Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trialIacopo Olivotto, Amos Katz, Ahmad Masri et al.|The Lancet|2020Cited by 1.2k
Vutrisiran in Patients with Transthyretin Amyloidosis with CardiomyopathyMarianna Fontana, Mathew S. Maurer, John L. Berk et al.|New England Journal of Medicine|2024Cited by 356